Interferon-γ: an overview of signals, mechanisms and functions
The DOI matches its Crossref record; 433 of the 443 references it cites were found in a registry or an index.
Abstract
Interferon-γ (IFN-γ) coordinates a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes. This article reviews the current understanding of IFN-γ ligand, receptor, ignal transduction, and cellular effects with a focus on macrophage responses and to a lesser extent, responses from other cell types that influence macrophage function during infection. The current model for IFN-γ signal transduction is discussed, as well as signal regulation and factors conferring signal specificity. Cellular effects of IFN-γ are described, including up-regulation of pathogen recognition, antigen processing and presentation, the antiviral state, inhibition of cellular proliferation and effects on apoptosis, activation of microbicidal effector functions, immunomodulation, and leukocyte trafficking. In addition, integration of signaling and response with other cytokines and pathogen-associated molecular patterns, such as tumor necrosis factor-α, interleukin-4, type I IFNs, and lipopolysaccharide are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the proteins encoded by these genes are all reported to be part of a signaling cascade upstream of interferon regulatory factor 1 (IRF1) and downstream of interferon-γ (IFNγ; ref. 50).”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [50]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“, peroxynitrite) to mediate cytotoxicity by a wide variety of mechanisms [281, 370, 371].”
InfluentialDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 2×
“, Stat1:Stat1:IRF-9, Stat1:Stat2:IRF-9) form during signaling [102, 116–118].”
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 7×
“Chaperones such as tapasin and GP96 implicated in aiding in the efficient assembly of peptide:MHC I complexes are also up-regulated by IFN- [4, 309, 310].”
InfluentialPeroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · cited 2×
“fend against a broad spectrum of pathogens [60, 61].”
Research works printed but not linked: 1
- Dey, 1999, Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis, J. Cell. Biochem., 72, 232, 10.1002/(sici)1097-4644(19990201)72:2<232::aid-jcb7>3.0.co;2-0 · DOI
Cited by
Items 401–500 of 1,014
Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study
Costa, C. H. N., Werneck, G. L., Costa, D. L., Holanda, T. A., de Aguiar, G. B., Carvalho, A. S., Cavalcanti, J. C., & Santos, L. S. (2010) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822010000400010 · Cited by 113
Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response
Malur, A., Mccoy, A. J., Arce, S., Barna, B. P., Kavuru, M. S., Malur, A. G., & Thomassen, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803504 · Cited by 108
“Production of IFN- by professional phagocytes and APCs has been suggested to play an important role in host defense against infection (29, 30).”
BackgroundYu, E., Ruiz‐Canela, M., Guasch‐Ferré, M., Zheng, Y., Toledo, E., Clish, C. B., Salas‐Salvadó, J., Liang, L., Wang, D. D., Corella, D., et al. (2017) · Journal of Nutrition · doi:10.3945/jn.116.241711 · Cited by 121
“IFN-g is a key molecule that orchestrates many pathways involved in inflammation by acting as a transcriptional regulator for immune-related genes (2).”
BackgroundZhang, X., Igorevich, O. A., Jiang, H., Liao, Q., Qiu, Q., Борисовна, С. И., Liu, Y., Amatore, C. A., & Huang, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201902734 · Cited by 111
IFN-γ, should not be ignored in SLE
Liu, W., Zhang, S., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954706 · Cited by 134
Lim, S.-A., & Cheong, K.-J. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0044 · Cited by 118
Essential Involvement of IFN-γ in Clostridium difficile Toxin A-Induced Enteritis
Ishida, Y., Maegawa, T., Kondo, T., Kimura, A., Iwakura, Y., Nakamura, S., & Mukaida, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3018 · Cited by 110
Mense, S. M., Sengupta, A., Lan, C., Zhou, M., Bentsman, G., Volsky, D. J., Whyatt, R. M., Perera, F. P., & Zhang, L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl046 · Cited by 109
“It also plays a major immunomodulatory role in astrocytes, and the activation of its signaling pathway leads to the expression of various inflammation-associated molecules (Schroder et al. 2004).”
BackgroundInfluentialSimvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
Agarwal, P., Rashighi, M., Essien, K. I., Richmond, J. M., Randall, L., Pazoki-Toroudi, H., Hunter, C. A., & Harris, J. E. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.529 · Cited by 110
“STAT1 is also phosphorylated by IL-12 (Schroder et al., 2004), a cytokine that induces IFN-g production, and certain STAT1 mutations in humans result in decreased IFN-g production after IL-12 stimulation (van de Veerdonk et al.”
BackgroundProduction of interferon-γ by myeloid cells – fact or fancy?
Bogdan, C., & Schleicher, U. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.004 · Cited by 125
Human Cathelicidin Peptide LL-37 Modulates the Effects of IFN-γ on APCs
Nijnik, A., Pistolic, J., Wyatt, A. W., Tam, S., & Hancock, R. E. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901491 · Cited by 125
“IFN- is one of the key cytokines in the immune response to intracellular pathogens, in antitumor immunity ( 20 , 21), and in the pathology of a number of inflammatory diseases (22–28).”
BackgroundDowall, S., Buttigieg, K. R., Findlay-Wilson, S., Rayner, E. L., Pearson, G., Miloszewska, A., Graham, V., Carroll, M. W., & Hewson, R. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1078045 · Cited by 109
“42, 43 For the immunogenicity of the MVA-NP vaccine, we compared the immune responses in mice with the type-I interferon receptor deficiency and the parental wild-type strain.”
BackgroundSmith, N. M., Wasserman, G. A., Coleman, F. T., Hilliard, K. L., Yamamoto, K., Lipsitz, E., Malley, R., Dooms, H., Jones, M. R., Quinton, L. J., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.43 · Cited by 111
Innate Immunity to Intracellular Pathogens: Balancing Microbial Elimination and Inflammation
Mitchell, G., & Isberg, R. R. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.005 · Cited by 111
“In addition, the release of cytokines by infected cells activates a signaling cascade that results in the secretion of IFN-γ by several types of immune cells (Schroder et al., 2004).”
BackgroundA post‐transcriptional pathway represses monocyte VEGF‐A expression and angiogenic activity
Ray, P. S., & Fox, P. L. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601774 · Cited by 109
“Interferon (IFN)-g is an inflammatory cytokine released by T-lymphocytes and natural killer cells that activate multiple host-defense responses in macrophages (Schroder et al, 2004).”
BackgroundWoodward, E. M., Christoffersen, M., Campos, J., Betancourt, A., Horohov, D. W., Scoggin, K. E. S., Squires, E. L., & Troedsson, M. H. T. (2013) · Reproduction · doi:10.1530/rep-12-0452 · Cited by 127
“A timely response to pathogens is important for an effective resolution of inflammation and preservation of tissue, and IFNG is important in the initiation of inflammation (Schroder et al. 2004).”
BackgroundWang, Q., Imamura, R., Motani, K., Kushiyama, H., Nagata, S., & Suda, T. (2013) · International Immunology · doi:10.1093/intimm/dxs161 · Cited by 108
Sinjari, B., Pizzicannella, J., D’Aurora, M., Zappacosta, R., Gatta, V., Fontana, A., Trubiani, O., & Diomede, F. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00633 · Cited by 105
“IFNγ synchronizes a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes (Schroder et al., 2004).”
BackgroundThe role of interferons type I, II and III in myositis: A review
Bolko, L., Jiang, W., Tawara, N., Landon‐Cardinal, O., Anquetil, C., Benvéniste, O., & Allenbach, Y. (2021) · Brain Pathology · doi:10.1111/bpa.12955 · Cited by 117
Francos-Quijorna, I., Sánchez-Petidier, M., Burnside, E. R., Badea, S. R., Espin, A. T., Marshall, L., de Winter, F., Verhaagen, J., Moreno‐Manzano, V., & Bradbury, E. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30467-5 · Cited by 111
Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection
Parkes, M., Halloran, P. F., & Hidalgo, L. G. (2016) · Transplantation · doi:10.1097/tp.0000000000001586 · Cited by 111
Quinteiro-Filho, W. M., Calefi, A. S., Cruz, D. S. G., Aloia, T. P. A., Zager, A., Astolfi-Ferreira, C. S., Ferreira, J. A. P., Sharif, S., & Palermo‐Neto, J. (2017) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2017.02.006 · Cited by 132
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Luo, Q., Zhang, L., Luo, C., & Jiang, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.017 · Cited by 104
Zhou, P., Cowled, C. J., Todd, S., Crameri, G. S., Virtue, E. R., Marsh, G. A., Klein, R., Shi, Z., Wang, L., & Baker, M. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003115 · Cited by 107
Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity
Kyriakides, T. R., Kim, H.-J., Zheng, C., Harkins, L., Tao, W., & Deschenes, E. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac5574 · Cited by 106
Cavalli, G., Hayashi, M., Jin, Y., Yorgov, D., Santorico, S. A., Holcomb, C. L., Rastrou, M. V., Erlich, H., Tengesdal, I. W., Dagna, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523482113 · Cited by 110
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Gasmi, A., Peana, M., Noor, S., Lysiuk, R., Menzel, A., Benahmed, A. G., & Bjørklund, G. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11094-4 · Cited by 109
Martín, S., Zou, J., Houlihan, D. F., & Secombes, C. J. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-150 · Cited by 113
Moneta, G. M., Marafon, D. P., Marasco, E., Rosina, S., Verardo, M., Fiorillo, C., Minetti, C., Bracci‐Laudiero, L., Ravelli, A., Benedetti, F. D., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40800 · Cited by 105
“IFNγ is a cytokine mainly produced by activated T cells and natural killer cells, and is a potent activator of macrophages (10).”
BackgroundInhibitory Effect of Gamma Interferon on BK Virus Gene Expression and Replication
Abend, J. R., Low, J. A., & Imperiale, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.01571-06 · Cited by 111
Mechanisms Employed by Herpes Simplex Virus 1 to Inhibit the Interferon Response
Paladino, P., & Mossman, K. L. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0074 · Cited by 101
Tassiulas, I. O., Hu, X., Ho, H. H., Kashyap, Y., Paik, P. K., Hu, Y., Lowell, C. A., & Ivashkiv, L. B. (2004) · Nature Immunology · doi:10.1038/ni1126 · Cited by 113
“Priming of cells by IFN-γ, specifically priming of lipopolysaccharide responses, was described in the 1970s, but the underlying mechanisms have not been well elucidate”
BackgroundWhitehead, A., Roach, J. L., Zhang, S., & Gálvez-Montosa, F. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.062075 · Cited by 105
“IFNG is a cytokine primarily involved in regulation of immune system genes in macrophages, but it also exhibits anti-proliferative and pro-apoptotic functions (Schroder et al., 2004).”
BackgroundSources of interferon-gamma (IFN-γ) in early immune response to Listeria monocytogenes
Thäle, C., & Kiderlen, A. F. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.07.003 · Cited by 104
Griffiths, J. I., Wallet, P., Pflieger, L. T., Stenehjem, D. D., Liu, X., Cosgrove, P. A., Leggett, N. A., McQuerry, J. A., Shrestha, G., Rossetti, M. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918937117 · Cited by 110
Yamanaka, Y. J., Berger, C. T., Sips, M., Cheney, P. C., Alter, G., & Love, J. C. (2012) · Integrative Biology · doi:10.1039/c2ib20167d · Cited by 104
Bam, M., Yang, X., Zhou, J., Ginsberg, J. P., Leyden, Q., Nagarkatti, P. S., & Nagarkatti, M. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9643-8 · Cited by 103
“IL-12 is known to induce IFNG expression (Puddu et al. 1997) via the JAK-STAT signaling pathway (Schroder et al. 2004).”
Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery
Malachowski, T., & Hassel, A. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.06.001 · Cited by 129
Current Approaches for Glioma Gene Therapy and Virotherapy
Banerjee, K., Núñez, F. J., Haase, S., McClellan, B. L., Faisal, S. M., Carney, S. V., Yü, J., Alghamri, M. S., Asad, A. S., Candia, A. J. N., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.621831 · Cited by 109
“Similarly another proinflammatory cytokine IFNγ, produced by NK, DC, and T-cells diminishes the invasive phenotype of glioma cells by inhibiting its interactions with extracellular matrix molecules (Schroder et al., 2004).”
BackgroundGoddard, E. T., Linde, M. H., Srivastava, S., Klug, G., Shabaneh, T. B., Iannone, S., Grzelak, C. A., Marsh, S. A., Riggio, A. I., Shor, R. E., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.011 · Cited by 107
Barber, A., Rynda, A., & Sentman, C. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902000 · Cited by 103
Mukherjee, S., Fried, A., Hussaini, R., White, R., Baidoo, J., Yalamanchi, S., & Banerjee, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0792-5 · Cited by 105
“Additionally, IFNγ also causes receptor-mediated activation of STAT1 [89, 90].”
BackgroundMazet, J. M., Mahale, J. N., Tong, O., Watson, R. A., Lechuga‐Vieco, A. V., Pirgova, G., Lau, V. W. C., Attar, M., Koneva, L. A., Sansom, S. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35948-9 · Cited by 110
Feng, G. L., Wood, K. J., & Bushell, A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181806a60 · Cited by 108
Dogi, C. A., Galdeano, C. M., & Perdigón, G. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.014 · Cited by 103
Modulation of chicken macrophage effector function by TH1/TH2 cytokines
He, H., Genovese, K. J., & Kogut, M. H. (2011) · Cytokine · doi:10.1016/j.cyto.2010.12.009 · Cited by 102
Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease
Litteljohn, D., Mangano, E., Clarke, M., Bobyn, J., Moloney, K., & Hayley, S. (2011) · Parkinson's Disease · doi:10.4061/2011/713517 · Cited by 93
“In contrast, the production of IFN-α and IFN-β does not appear to be under the control of specific cell types, and indeed, most cells appear to be able to secrete these cytokines in response to viral insult [103].”
BackgroundThe detrimental impact of extracellular bacterial proteases on wound healing
Lindsay, S., Oates, A., & Bourdillon, K. (2017) · International Wound Journal · doi:10.1111/iwj.12790 · Cited by 109
Ng, C. T., Fong, L. Y., & Abdullah, M. N. H. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156208 · Cited by 106
Brien, J. D., Daffis, S., Lazear, H. M., Cho, H., Suthar, M. S., Gale, M., & Diamond, M. S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002230 · Cited by 91
“Since previous studies have defined a role of IRF-1 in mediating the antiviral effects of IFN-c signaling [54], we evaluated the contribution of IRF-1 to the antiviral effects of either IFN-b or IFN-c in Mw after WNV infection.”
Parent, M. A., Wilhelm, L. B., Kummer, L. W., Szaba, F. M., Mullarky, I. K., & Smiley, S. T. (2006) · Infection and Immunity · doi:10.1128/iai.00185-06 · Cited by 100
Yu, Q., Zeng, K., Ma, X., Song, F., Jiang, Y., Tu, P., & Wang, X. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.05.010 · Cited by 111
Fernandez-Boyanapalli, R., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Dinauer, M. C., Riches, D. W. H., Henson, P. M., Byrne, A., & Bratton, D. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001778 · Cited by 99
“, increased ability to kill ingested microbes that is ablated by inhibitors of iNOS) (18, 42, 43).”
BackgroundThe role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease
Morales-Mantilla, D. E., & King, K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0139-3 · Cited by 99
Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
Duncan, C. J. A., Randall, R. E., & Hambleton, S. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.08.017 · Cited by 100
“While expression of the IFNγ receptor (IFNGR) is, like that of the IFN-I receptor (IFNAR), widespread, the production of IFNγ is tightly controlled and restricted to specialised immune cells [18].”
Autophagy Facilitates IFN-γ-induced Jak2-STAT1 Activation and Cellular Inflammation*
Chang, Y., Tsai, C.-C., Huang, W., Wang, C.-Y., Chen, C.-L., Lin, Y.-S., Kai, J., Hsieh, C., Cheng, Y.-L., Choi, P.-C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133355 · Cited by 81
Epigenetic Control of Interferon-Gamma Expression in CD8 T Cells
de Araujo‐Souza, P. S., Hanschke, S. C. H., & Viola, J. P. B. (2015) · Journal of Immunology Research · doi:10.1155/2015/849573 · Cited by 106
“Mice with targeted disruptions of the Ifng gene or Ifng gene receptor 1 are highly susceptible to a variety of bacteria, protozoans, and virus infection [1].”
BackgroundBoulet, S., Song, R., Kamya, P., Bruneau, J., Shoukry, N. H., Tsoukas, C. M., & Bernard, N. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902621 · Cited by 99
Park, I.-K., Shultz, L. D., Letterio, J. J., & Gorham, J. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5666 · Cited by 97
“TGF- 1’s inhibition of IFN- -induced Jak1 and Stat1 phosphorylation at very early time points (within 15 min of cytokine exposure) does not require new protein synthesis, but, nevertheless, requires Shp-1, because TGF- 1 did not inhibit IFN- -induced Stat1 tyrosine phosphorylation in Shp-1-deficient mev/mev T cells.”
BackgroundInfluentialInterferon-γ Inhibits Ebola Virus Infection
Rhein, B. A., Powers, L. S., Rogers, K. J., Anantpadma, M., Singh, B. K., Sakurai, Y., Bair, T., Miller-Hunt, C. L., Sinn, P. L., Davey, R. A., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005263 · Cited by 105
“Finally, as IFNγ potently activates T cell responses through enhancement of phagocytosis and antigen presentation [19] , such stimulation of antigen presentation would be predicted to enhance adaptive immune responses to in vivo infection.”
BackgroundInfluentialOncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
Bourgeois‐Daigneault, M., Roy, D. G., Falls, T. J., Twumasi‐Boateng, K., St-Germain, L. E., Marguerie, M., Garcia, V., Selman, M., Jennings, V. A., Pettigrew, J. L., et al. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.1 · Cited by 111
Inserra, A., Mastronardi, C. A., Rogers, G., Licinio, J., & Wong, M.-L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 96
Nanoparticulate immunotherapy for cancer
Kapadia, C. H., Perry, J. L., Tian, S., Luft, J. C., & DeSimone, J. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.062 · Cited by 100
Hou, X., Zhou, R., Wei, H., Sun, R., & Tian, Z. (2009) · Hepatology · doi:10.1002/hep.22725 · Cited by 95
Antigen-presenting innate lymphoid cells orchestrate neuroinflammation
Grigg, J. B., Shanmugavadivu, A., Regen, T., Parkhurst, C. N., Ahmed, A., Joseph, A. M., Mazzucco, M. R., Gronke, K., Diefenbach, A., Eberl, G., et al. (2021) · Nature · doi:10.1038/s41586-021-04136-4 · Cited by 99
Type III IFNs: New layers of complexity in innate antiviral immunity
Ank, N., & Paludan, S. R. (2009) · BioFactors · doi:10.1002/biof.19 · Cited by 105
Dussurget, O., Bierne, H., & Cossart, P. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00050 · Cited by 111
“In addition, IFN-γ controls differentiation of T cells in Th1 effector cells, antigen processing and presentation by antigen-presenting cells, which participate to cellular immunity against intracellular pathogens (Schroder, 2003; Hu and Ivashkiv, 2009 ).”
BackgroundBlank, F., Gerber, P., Rothen-Rutishauser, B., Sakulkhu, U., Salaklang, J., De Peyer, K., Gehr, P., Nicod, L. P., Hofmann, H., Geiser, T., et al. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.541293 · Cited by 97
“IFNg is a type-II interferon secreted by several immune cells (DCs, Th1, T cells, and NKT) with anti-viral, anti-tumor, and immunoregulatory effects induced through regulation of about 30 genes (Schroder et al. 2004).”
BackgroundMeta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm
Stather, P., Sidloff, D. A., Dattani, N., Gokani, V. J., Choke, E. T. C., Sayers, R. D., & Bown, M. J. (2014) · British journal of surgery · doi:10.1002/bjs.9593 · Cited by 97
Cytokines and Interferons: Types and Functions
Ferreira, V. L., Borba, H. H. L., Bonetti, A. D. F., Leonart, L. P., & Pontarolo, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74550 · Cited by 97
Kobayashi, Y., Lim, S., & Yamaguchi, H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.011 · Cited by 102
Wang, C., Hyams, B., Allen, N. C., Cautivo, K. M., Monahan, K., Zhou, M., Dahlgren, M. W., Lizama, C. O., Matthay, M. A., Wolters, P. J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.032 · Cited by 100
Integration of cytokine and heterologous receptor signaling pathways
Bezbradica, J. S., & Medzhitov, R. M. (2009) · Nature Immunology · doi:10.1038/ni.1713 · Cited by 109
“Moreover, cytokine-activated STAT (IFN-γ-activated STAT1) can further prime bactericidal and antigen-presenting functions in macrophages downstream of TLR and FcR signals by inducing the transcription of genes encoding effector molecules responsible for pathogen killing (inducible nitric oxide synthase (iNos) and phag…”
BackgroundAging and Interferons: Impacts on Inflammation and Viral Disease Outcomes
Feng, E., Balint, E., Poznanski, S. M., Ashkar, A. A., & Loeb, M. (2021) · Cells · doi:10.3390/cells10030708 · Cited by 82
Qi, Y., Jiang, H., Wu, W., Zhang, F., Tian, S. I. P., Fan, W., Liu, Y., Amatore, C. A., & Huang, W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c01857 · Cited by 96
Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages
Cho, Y.-C., Kim, H. J., Kim, Y., Lee, K. Y., Choi, H. J., Lee, I., & Kang, B. Y. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.12.017 · Cited by 105
“IFN-γ signaling profoundly affects the activities of macrophages including the stimulation of antimicrobial and antitumor activity, the upregulation of presentation thorough MHC I and II, the inhibition of cellular proliferation, the modulation of apoptosis, and the orchestration of leukocyte–endothelium interactions…”
BackgroundRazaghi, A., Owens, L., & Heimann, K. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.022 · Cited by 103
Borg, N., Alter, C., Görldt, N., Jacoby, C., Ding, Z., Steckel, B., Quast, C., Bönner, F., Friebe, D., Temme, S., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.023365 · Cited by 95
Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus
Roth, S. H., Danan-Gotthold, M., Ben-Izhak, M., Rechavi, G., Cohen, C. J., Louzoun, Y., & Levanon, E. Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.036 · Cited by 92
“Moreover, SLE has several characteristics that may promote the immunogenicity of RNA editing, such as the upregulation of epitope presentation pathway by IFNs and the accumulation of dead cell debris (Boehm et al., 1997; Lipsky, 2001; Rusinova et al., 2013; Schroder et al., 2004).”
BackgroundCOVID-19: Inflammatory Profile
Wang, Y., & Perlman, S. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-012417 · Cited by 101
Li, X., Shao, M., Zeng, X., Qian, P., & Huang, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00764-4 · Cited by 100
Immunological Perspective: Helicobacter pylori Infection and Gastritis
Yang, H., & Hu, B. (2022) · Mediators of Inflammation · doi:10.1155/2022/2944156 · Cited by 105
Miller, J. C., Ma, Y., Bian, J., Sheehan, K. C. F., Zachary, J. F., Weis, J. H., Schreiber, R. D., & Weis, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8492 · Cited by 94
“Both classes of IFNs trigger the Jak-Stat pathway during their activation and share the ability to activate the transcription factors Stat1 and IFN regulatory factor (IRF) 1 (IRF1) (63).”
BackgroundRoles for T and NK Cells in the Innate Immune Response to Shigella flexneri
Le-Barillec, K., Magalhaes, J. G., Corcuff, E., Thuizat, A., Sansonetti, P. J., Phalipon, A., & Santo, J. P. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1735 · Cited by 94
Vollmer-Conna, U. S., Piraino, B., Cameron, B., Davenport, T. A., Hickie, I. B., Wakefield, D., Lloyd, A. R., & Dubbo Infection Outcomes Study Group (2008) · Clinical Infectious Diseases · doi:10.1086/592967 · Cited by 99
“These findings are concordant with the substantial evidence for the central role of both IFN-g and IL-10 in determining the characteristics of the innate and adaptive host responses to a wide range of pathogens [ 24 , 25] and, therefore, determining susceptibility to many intracellular bacterial, parasitic, and viral…”
ResultNon-HLA Antibodies to Immunogenic Epitopes Predict the Evolution of Chronic Renal Allograft Injury
Sigdel, T. K., Li, L., Tran, T. Q., Khatri, P., Naesens, M., Sansanwal, P., Dai, H., Hsieh, S., & Sarwal, M. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060596 · Cited by 99
Ovadje, P., Saleem, A., Guerrero, J.-A., Arnason, J. T., & Pandey, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11485 · Cited by 101
“3 Has both pro- and anti-apoptotic activities; a major transcription factor in various cell signaling pathways [34, 35]”
BackgroundPolyfunctional response by Imm TAC ( IMC gp100) redirected CD 8 + and CD 4 + T cells
Boudousquié, C., Bossi, G., Hurst, J. M., Rygiel, K. A., Jakobsen, B. K., & Hassan, N. J. (2017) · Immunology · doi:10.1111/imm.12779 · Cited by 97
Dufour, A., Bellac, C. L., Eckhard, U., Solis, N., Klein, T., Kappelhoff, R., Fortelny, N., Jobin, P. G., Rozmus, J., Mark, J. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04717-4 · Cited by 98
Jiang, J., Pi, J., Jin, H., & Cai, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27654 · Cited by 93
Reuter, M. A., Pombo, C., & Betts, M. R. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.05.005 · Cited by 102
“likely a result of decreased T-bet expression in chronic progressors compared to EC [86].”
BackgroundSTAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
Spitzner, M., Ebner, R., Wolff, H., Ghadimi, B., Wienands, J., & Grade, M. (2014) · Cancers · doi:10.3390/cancers6041986 · Cited by 90
“effector proteins of cytokine- or hormone-induced pathways that control the development, proliferation or differentiation, as well as the homeostasis of many cell types [10–13].”
BackgroundQuorum sensing: dynamic response of Pseudomonas aeruginosa to external signals
Wagner, V., Frelinger, J. G., Barth, R. K., & Iglewski, B. H. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2005.12.002 · Cited by 93
“Nevertheless, IFN-g might be expected to have a more important role in viral and intracellular bacterial infections such as mycobacteria rather than in infections of extracellular bacteria such as Pseudomonas [ 16 ].”
BackgroundInfluentialKoga, M., Kai, H., Yasukawa, H., Yamamoto, T., Kawai, Y., Kato, S., Kusaba, K., Kai, M., Egashira, K., Kataoka, Y., et al. (2007) · Circulation Research · doi:10.1161/circresaha.106.147256 · Cited by 86
Oriss, T. B., Raundhal, M. R., Morse, C., Huff, R., Das, S., Hannum, R., Gauthier, M. C., Scholl, K., Chakraborty, K., Nouraie, M. S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91019 · Cited by 97
Schleicher, U., Hesse, A., & Bogdan, C. (2005) · Blood · doi:10.1182/blood-2004-05-1749 · Cited by 90
Chen, D. S., Soen, Y., Stuge, T. B., Lee, P. P., Weber, J. S., Brown, P. O., & Davis, M. M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020265 · Cited by 92
Qazi, M. R., Abedi, M. R., Nelson, B. D., DePierre, J. W., & Abedi‐Valugerdi, M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.009 · Cited by 97
Haverkamp, M. H., van Dissel, J. T., & Holland, S. M. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.029 · Cited by 93
Garlet, G. P., Cardoso, C. R. D. B., Campanelli, A. P., Garlet, T. P., Ávila-Campos, M. J., Cunha, F. Q., & Silva, J. S. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.01.010 · Cited by 92
Metadata
- Authors
- Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A.
- Affiliations
- The University of Queensland (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Hume, David A
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-02
- Volume
- 75
- Issue
- 2
- Pages
- 163-189
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167017590
- Cited by
- 4,120
- References
- 443
- Citations by year
- 2026: 141 · 2025: 166 · 2024: 208 · 2023: 231 · 2022: 229 · 2021: 252 · 2020: 243 · 2019: 213 · 2018: 193 · 2017: 225 · 2016: 236 · 2015: 246 · 2014: 209 · 2013: 224 · 2012: 195
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon-gamma, IFN-gamma receptor, signal transduction, macrophage response, transcriptional regulation, antigen processing and presentation, antiviral state, apoptosis, immunomodulation, leukocyte migration, cytokine signaling, pathogen-associated molecular patterns
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Interferon-gamma, Macrophages, Signal Transduction, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.